Plainly spelling out the risks, Federal Reserve chairman Ben S. Bernanke said last week that inflation remained “uncomfortably high.”

Investors who randomly sweep up shares in companies that are buying back stock with the goal of beating the market are likely to be disappointed.

Newsletter bulls are charging hard. Time to take cover?

Slice by slice, government is paying for much of the insurance pie.

Compared with the late-’90s technology boom, there are few initial public offerings, making it harder to determine when an Internet downturn has begun.

Pfizer plans to ask for approval of torcetrapib, a heart drug crucial to the company’s future, despite evidence that the drug increases blood pressure.

CHICAGO, Nov. 30 (Reuters) — Cardinal Health said Thursday that it planned to divest itself of its ailing drug manufacturing business, sending its shares up more than 5 percent.